Skip to main content
. 2023 Oct 12;34(4):2512–2523. doi: 10.1007/s00330-023-10085-5

Table 5.

Renal excretion of gadolinium-based contrast agents

Name Ligand Structure Ionicity Renal excretion
(Elimination T½; hours — near complete elimination in 6 T½)
Normal RF Moderately reduced RF Severely reduced RF
(eGFR > 60 mL/min) (eGFR 30–60 mL/min) (eGFR < 30 mL/min)
Gadopentetate DTPA Linear Ionic 1.6 4.0 30.0
Gadodiamide DTPA-BMA Linear Nonionic 1.3 NA 27.4
Gadobenate BOPTA Linear Ionic 1.2–2.0 5.6 9.2
Gadoxetate EOB-DTPA Linear Ionic 1.0 2.2 20.0
Gadoteridol HP-DO3A Macrocyclic Nonionic 1.6 6.9 9.5
Gadobutrol BT-DO3A Macrocyclic Nonionic 1.8 5.8 17.6
Gadoterate DOTA Macrocyclic Ionic 1.6 5.1 13.9
Gadopiclenol Piclen Macrocyclic Nonionic 1.6–1.9 3.8 11.7

NA, no data available; RF, renal function; eGFR, estimated glomerular filtration rate; , half-life

Sources: see references in text